ABDOMEN - Tumor fibrosis as a prognostic factor in ductal pancreatic carcinoma

被引:0
|
作者
Graewert, Stephanie
机构
关键词
D O I
10.1055/a-1993-0063
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:287 / 288
页数:2
相关论文
共 50 条
  • [21] Survival and Prognostic Factors in Patients With Pancreatic Colloid Carcinoma Compared With Pancreatic Ductal Adenocarcinoma
    Khalil, Lana
    Huang, Zhonglu
    Zakka, Katerina
    Jiang, Renjian
    Penley, McKenna
    Alese, Olatunji B.
    Shaib, Walid L.
    Wu, Christina
    Behera, Madhusmita
    Reid, Michelle D.
    El-Rayes, Bassel F.
    Akce, Mehmet
    PANCREAS, 2023, 52 (01) : E75 - E84
  • [22] Prognostic significance of circulating tumor microemboli in patients with pancreatic ductal adenocarcinoma
    Wu, Guangdong
    Zhu, Rongrong
    Li, Yatong
    Zhao, Yupei
    Dai, Menghua
    ONCOLOGY LETTERS, 2018, 15 (05) : 7376 - 7382
  • [23] Prognostic significance of tumor budding in resected pancreatic ductal adenocarcitionia (PDAC)
    Peixoto, Renata D'Alpino
    O'Connor, Kate
    Li-Chang, Hector Hugo
    Kalloger, Steve
    Renouf, Daniel John
    Schaeffer, David
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [24] Thrombospondin-1 expression as a prognostic predictor of pancreatic ductal carcinoma
    Tobita, K
    Kijima, H
    Dowaki, S
    Oida, Y
    Kashiwagi, H
    Ishii, M
    Sugio, Y
    Sekka, T
    Ohtani, Y
    Tanaka, M
    Inokuchi, S
    Makuuchi, H
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2002, 21 (06) : 1189 - 1195
  • [25] Ampullary Carcinoma-prognostic and Therapeutical Contrast to Pancreatic Ductal Adenocarcinoma
    Giehl-Brown, Esther
    Weitz, Juergen
    Distler, Marius
    ZENTRALBLATT FUR CHIRURGIE, 2022, 147 (02): : 160 - 167
  • [26] Stromal Palladin Expression Is an Independent Prognostic Factor in Pancreatic Ductal Adenocarcinoma
    Sato, Daisuke
    Tsuchikawa, Takahiro
    Mitsuhashi, Tomoko
    Hatanaka, Yutaka
    Marukawa, Katsuji
    Morooka, Asami
    Nakamura, Toru
    Shichinohe, Toshiaki
    Matsuno, Yoshihiro
    Hirano, Satoshi
    PLOS ONE, 2016, 11 (03):
  • [27] The Levels of Tumor Markers in Pancreatic Neuroendocrine Carcinoma and Their Values in Differentiation Between Pancreatic Neuroendocrine Carcinoma and Pancreatic Ductal Adenocarcinoma
    Zhuge, Xiaoling
    Guo, Chuangen
    Chen, Yu
    Feng, Limin
    Jia, Rongfei
    Zhao, Ying
    Sun, Ke
    Wang, Zhongqiu
    Chen, Xiao
    PANCREAS, 2018, 47 (10) : 1290 - 1295
  • [28] Tumor-infiltrating OX40+ lymphocytes is an independent positive prognostic factor for patients with pancreatic ductal adenocarcinoma
    Qiwei Zhang
    Weiwei Rui
    Yongsheng Jiang
    Fei Yuan
    Yong Chen
    Xiaoxia Guo
    Yu Zhou
    Zhiyuan Wu
    Chaofu Wang
    Xiaoyi Ding
    Clinical and Translational Oncology, 2022, 24 : 2029 - 2038
  • [29] Reappraisal of the clinical significance of tumor size in patients with pancreatic ductal carcinoma
    Shimada, Kazuaki
    Sakamoto, Yoshihiro
    Sano, Tsuyoshi
    Kosuge, Tomoo
    Hiraoka, Nobuyoshi
    PANCREAS, 2006, 33 (03) : 233 - 239
  • [30] Tumor-infiltrating OX40+ lymphocytes is an independent positive prognostic factor for patients with pancreatic ductal adenocarcinoma
    Zhang, Qiwei
    Rui, Weiwei
    Jiang, Yongsheng
    Yuan, Fei
    Chen, Yong
    Guo, Xiaoxia
    Zhou, Yu
    Wu, Zhiyuan
    Wang, Chaofu
    Ding, Xiaoyi
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (10): : 2029 - 2038